See more : Venator Materials PLC (VNTR) Income Statement Analysis – Financial Results
Complete financial analysis of Sarepta Therapeutics, Inc. (0L35.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sarepta Therapeutics, Inc., a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- Lightning Minerals Ltd (L1M.AX) Income Statement Analysis – Financial Results
- Axis Bank Limited (AXB.L) Income Statement Analysis – Financial Results
- Amylyx Pharmaceuticals, Inc. (AMLX) Income Statement Analysis – Financial Results
- AIXTRON SE (AIXA.DE) Income Statement Analysis – Financial Results
- Varta AG (VAR1.DE) Income Statement Analysis – Financial Results
Sarepta Therapeutics, Inc. (0L35.L)
About Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of duchenne in patients with confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping. The company is also developing AMONDYS 45, a product candidate that uses phosphorodiamidate morpholino oligomer chemistry and exon-skipping technology to skip exon 45 of the dystrophin gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; and SRP-9003, a limb-girdle muscular dystrophies gene therapy program. It has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children's Hospital; Lysogene; Duke University; Genethon; and StrideBio. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.24B | 933.01M | 701.89M | 540.10M | 380.83M | 301.03M | 154.58M | 5.42M | 1.25M | 9.76M | 14.22M | 37.33M | 46.99M | 29.42M | 17.59M | 21.26M | 10.99M | 115.29K | 4.78M | 430.46K | 969.87K | 836.78K | 706.10K | 1.30M | 100.00K | 200.00K | 100.00K | 100.00K | 100.00K |
| Cost of Revenue | 150.34M | 139.99M | 97.05M | 63.38M | 56.59M | 34.19M | 7.35M | 130.00K | 146.19M | 94.10M | 90.28M | 51.93M | 35.93M | 27.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -416.50K | 0.00 | -200.00K | -500.00K | -500.00K | 0.00 |
| Gross Profit | 1.09B | 793.02M | 604.84M | 476.72M | 324.25M | 266.84M | 147.23M | 5.29M | -144.94M | -84.35M | -76.07M | -14.60M | 11.06M | 1.96M | 17.59M | 21.26M | 10.99M | 115.29K | 4.78M | 430.46K | 969.87K | 836.78K | 706.10K | 1.71M | 100.00K | 400.00K | 600.00K | 600.00K | 100.00K |
| Gross Profit Ratio | 87.91% | 85.00% | 86.17% | 88.26% | 85.14% | 88.64% | 95.24% | 97.60% | -11,567.52% | -864.47% | -534.95% | -39.12% | 23.54% | 6.67% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 132.10% | 100.00% | 200.00% | 600.00% | 600.00% | 100.00% |
| Research & Development | 877.39M | 877.09M | 771.18M | 722.34M | 560.91M | 401.84M | 166.71M | 188.27M | 146.39M | 94.23M | 72.91M | 52.40M | 66.86M | 35.97M | 24.40M | 29.00M | 34.76M | 25.35M | 17.12M | 20.74M | 15.28M | 22.41M | 12.75M | 9.27M | 6.70M | 6.30M | 2.70M | 1.70M | 2.10M |
| General & Administrative | 453.27M | 451.42M | 282.66M | 317.88M | 284.81M | 209.98M | 119.85M | 81.20M | 75.04M | 49.32M | 31.59M | 14.63M | 16.06M | 14.38M | 8.70M | 9.80M | 9.33M | 7.75M | 5.18M | 4.74M | 4.56M | 3.76M | 3.36M | 2.27M | 1.70M | 1.60M | 1.30M | 600.00K | 600.00K |
| Selling & Marketing | 28.60M | 14.60M | 7.70M | 0.00 | 0.00 | -2.22M | 2.83M | 2.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 481.87M | 451.42M | 282.66M | 317.88M | 284.81M | 207.76M | 122.68M | 83.75M | 75.04M | 49.32M | 31.59M | 14.63M | 16.06M | 14.38M | 8.70M | 9.80M | 9.33M | 7.75M | 5.18M | 4.74M | 4.56M | 3.76M | 3.36M | 2.27M | 1.70M | 1.60M | 1.30M | 600.00K | 600.00K |
| Other Expenses | 1.56M | 714.00K | 706.00K | 662.00K | 849.00K | -656.00K | 1.98M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 416.50K | 0.00 | 200.00K | 500.00K | 500.00K | 0.00 |
| Operating Expenses | 1.36B | 1.33B | 1.05B | 1.04B | 846.57M | 610.47M | 290.44M | 272.02M | 221.44M | 143.55M | 104.50M | 67.03M | 82.92M | 50.35M | 33.09M | 38.80M | 44.09M | 33.10M | 22.30M | 25.47M | 19.84M | 26.18M | 16.11M | 11.96M | 8.40M | 8.10M | 4.50M | 2.80M | 2.70M |
| Cost & Expenses | 1.51B | 1.47B | 1.15B | 1.10B | 903.16M | 644.66M | 297.80M | 272.15M | 221.44M | 143.55M | 104.50M | 67.03M | 82.92M | 50.35M | 33.09M | 38.80M | 44.09M | 33.10M | 22.30M | 25.47M | 19.84M | 26.18M | 16.11M | 11.54M | 8.40M | 7.90M | 4.00M | 2.30M | 2.70M |
| Interest Income | 85.97M | 16.49M | 354.00K | 2.97M | 7.24M | 6.81M | 1.81M | 507.00K | 0.00 | 0.00 | 0.00 | 0.00 | 677.00K | 0.00 | 0.00 | 0.00 | 0.00 | 1.91M | 840.50K | 0.00 | 491.10K | 0.00 | 0.00 | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 22.01M | 53.25M | 63.53M | 59.95M | 30.67M | 33.71M | 5.78M | 1.89M | 0.00 | 0.00 | 326.00K | 0.00 | 90.00K | 344.00K | 454.00K | 344.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 58.89M | 54.60M | 49.34M | 39.74M | 30.55M | 12.25M | 8.09M | 5.61M | 5.25M | 3.69M | 1.28M | 1.53M | 1.30M | 1.46M | 1.38M | 1.47M | 2.01M | 2.09M | 2.00M | 1.89M | 1.48M | 1.33M | 556.47K | 416.50K | 300.00K | 200.00K | 500.00K | 500.00K | 500.00K |
| EBITDA | -439.20M | -582.12M | -306.08M | -453.38M | -652.66M | -316.66M | -34.75M | -261.12M | -214.78M | -129.97M | -88.42M | -27.59M | -34.63M | -19.47M | -14.13M | -22.48M | -25.15M | -28.98M | -14.68M | -22.89M | -17.39M | -24.01M | -14.85M | -9.82M | -8.00M | -7.60M | -3.40M | -1.70M | -2.10M |
| EBITDA Ratio | -35.32% | -50.75% | -58.72% | -98.00% | -123.26% | -113.86% | -154.43% | -4,920.31% | -17,572.55% | -1,342.73% | -480.04% | 170.81% | -146.73% | -27.09% | -28.04% | -43.83% | -328.17% | -26,795.39% | -324.40% | -5,379.35% | -2,181.22% | -2,333.87% | -329.00% | -757.30% | -7,900.00% | 5,750.00% | -3,800.00% | -1,900.00% | -2,100.00% |
| Operating Income | -267.82M | -536.20M | -449.71M | -564.16M | -522.32M | -343.63M | -171.64M | -266.73M | -220.18M | -133.79M | -90.28M | -29.70M | -35.93M | -20.93M | -15.51M | -27.46M | -33.11M | -32.98M | -17.52M | -25.04M | -18.87M | -25.34M | -15.40M | -10.24M | -8.30M | -7.70M | -3.90M | -2.20M | -2.60M |
| Operating Income Ratio | -21.54% | -57.47% | -64.07% | -104.46% | -137.15% | -114.15% | -111.03% | -4,920.31% | -17,572.55% | -1,371.21% | -634.95% | -79.57% | -76.46% | -71.16% | -88.18% | -129.16% | -301.38% | -28,608.52% | -366.16% | -5,817.95% | -1,945.99% | -3,028.39% | -2,181.36% | -789.41% | -8,300.00% | -3,850.00% | -3,900.00% | -2,200.00% | -2,600.00% |
| Total Other Income/Expenses | -252.27M | -153.76M | 40.76M | 11.10M | -8.32M | -18.98M | 123.01M | -535.00K | 154.00K | -2.00M | -21.70M | -92.17M | 33.61M | -11.24M | -9.20M | -6.41M | 5.94M | 1.91M | 840.50K | 266.30K | 4.26M | -4.02M | 7.12M | 1.00M | -100.00K | -19.00M | 400.00K | 200.00K | 0.00 |
| Income Before Tax | -520.10M | -689.96M | -418.95M | -553.07M | -713.88M | -362.61M | -48.63M | -267.27M | -220.03M | -135.79M | -111.99M | -121.29M | -2.32M | -23.95M | -24.71M | -23.95M | -28.15M | -31.07M | -16.68M | -24.78M | -14.62M | -29.36M | -8.28M | -9.24M | -8.40M | -26.70M | -3.50M | -2.00M | -2.60M |
| Income Before Tax Ratio | -41.83% | -73.95% | -59.69% | -102.40% | -187.45% | -120.45% | -31.46% | -4,930.18% | -17,560.26% | -1,391.71% | -787.57% | -324.91% | -4.93% | -81.42% | -140.49% | -112.67% | -256.27% | -26,951.81% | -348.59% | -5,756.08% | -1,507.08% | -3,508.56% | -1,172.41% | -712.22% | -8,400.00% | -13,350.00% | -3,500.00% | -2,000.00% | -2,600.00% |
| Income Tax Expense | 15.88M | 13.53M | -168.00K | 1.06M | 1.20M | -692.00K | 2.06M | -7.62M | -5.25M | -1.69M | 20.42M | 91.58M | -34.91M | 11.24M | 9.65M | 6.41M | -5.94M | 0.00 | 0.00 | 0.00 | -4.26M | 4.02M | 11.52M | 0.00 | 0.00 | 19.00M | -300.00K | -100.00K | 0.00 |
| Net Income | -535.98M | -703.49M | -418.78M | -554.13M | -715.08M | -361.92M | -50.69M | -267.27M | -220.03M | -135.79M | -111.99M | -121.29M | -2.32M | -32.18M | -25.16M | -23.95M | -27.17M | -31.07M | -16.68M | -24.78M | -14.62M | -29.36M | -26.93M | -9.24M | -8.30M | -26.70M | -3.60M | -2.10M | -2.60M |
| Net Income Ratio | -43.11% | -75.40% | -59.66% | -102.60% | -187.77% | -120.22% | -32.79% | -4,930.18% | -17,560.26% | -1,391.71% | -787.57% | -324.91% | -4.93% | -109.37% | -143.07% | -112.67% | -247.31% | -26,951.81% | -348.59% | -5,756.08% | -1,507.08% | -3,508.56% | -3,813.21% | -712.22% | -8,300.00% | -13,350.00% | -3,600.00% | -2,100.00% | -2,600.00% |
| EPS | -5.80 | -8.03 | -5.15 | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 | -5.20 | -3.39 | -3.31 | -5.14 | -0.11 | -1.74 | -1.62 | -2.07 | -3.02 | -3.54 | -2.24 | -4.13 | -2.94 | -6.86 | -7.21 | -2.96 | -3.71 | -13.57 | -2.14 | -1.50 | -2.17 |
| EPS Diluted | -5.80 | -8.03 | -5.15 | -7.11 | -9.71 | -5.46 | -0.86 | -5.49 | -5.20 | -3.39 | -3.31 | -5.14 | -0.11 | -1.74 | -1.62 | -2.07 | -3.02 | -3.54 | -2.24 | -4.13 | -2.94 | -6.86 | -7.21 | -2.96 | -3.71 | -13.57 | -2.14 | -1.50 | -2.17 |
| Weighted Avg Shares Out | 92.40M | 87.56M | 81.26M | 77.96M | 73.62M | 66.25M | 58.82M | 48.68M | 42.29M | 40.03M | 33.83M | 23.60M | 21.60M | 18.54M | 15.52M | 11.58M | 8.99M | 8.78M | 7.44M | 6.00M | 4.97M | 4.28M | 3.73M | 3.12M | 2.24M | 1.97M | 1.68M | 1.40M | 1.20M |
| Weighted Avg Shares Out (Dil) | 92.40M | 87.56M | 81.26M | 77.96M | 73.62M | 66.25M | 58.82M | 48.70M | 42.29M | 40.03M | 33.85M | 23.60M | 21.60M | 18.54M | 15.52M | 11.58M | 8.99M | 8.78M | 7.44M | 6.00M | 4.97M | 4.28M | 3.73M | 3.12M | 2.24M | 1.97M | 1.68M | 1.40M | 1.20M |
Source: https://incomestatements.info
Category: Stock Reports